Administration of levamlodipine (2.5 mg) as a single dose gives maximum plasma concentration (C) of 8.3 to 9.3 ng/mL in 2 to 3 hrs (T). It is extensively (about 90%) converted to inactive metabolites via hepatic metabolism with 10% of the parent compound and 60% of the metabolites excreted in the urine. Levamlodipine shows approximately 93% plasma protein binding in hypertensive patients. The mean AUC value (t = 48 hrs) of levamlodipine tablets (2.5 mg) is . The plasma elimination half-life of levamlodipine has been found to be .